Private Prescription Cost Analysis: Wegovy vs Mounjaro
Why Private Prescription Makes Sense for Wegovy vs Mounjaro
The NHS route for weight management medications involves lengthy processes that many patients find frustrating. GP referrals to specialist weight management services often result in 6-12 month waiting lists, with strict eligibility criteria that exclude many suitable candidates. When comparing whether Wegovy is cheaper than Mounjaro through private prescription, patients gain immediate access without bureaucratic delays. Private prescribing allows for personalised treatment decisions based on individual circumstances rather than rigid NHS protocols.
EverydayMeds operates as a GPhC-registered pharmacy (#9012878) providing the same pharmaceutical-grade medications available through NHS services. The key difference lies in accessibility and convenience — our 3-minute clinical assessment replaces months of waiting for specialist appointments. Both Wegovy and Mounjaro require prescription-only medicine status, but private prescribing removes the gatekeeping that often prevents suitable patients from accessing treatment promptly.
Detailed Price Comparison: Is Wegovy Cheaper Than Mounjaro?
When evaluating whether Wegovy is cheaper than Mounjaro, the dose escalation schedules create different cost patterns. Wegovy begins at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Mounjaro's private pricing typically starts around £150-200 per pen across all doses, making Wegovy significantly more affordable during the initial titration period.
Our bundle pricing offers additional value for patients planning their treatment journey. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering the first 8 weeks of treatment. The Progress Trio bundle (0.5mg, 1mg & 1.7mg) provides 12 weeks of medication for £369.99. New customers apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access these competitive rates. These prices represent the final cost with discounts already applied.
Clinical Evidence Supporting Wegovy's Value Proposition
The STEP clinical trial programme demonstrates Wegovy's effectiveness in weight management when used alongside a reduced-calorie diet and increased physical activity. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo. The STEP 5 trial confirmed sustained weight loss of approximately 15.2% at 2 years.
Recent cardiovascular outcome data from the SELECT trial showed a 20% reduction in major cardiovascular events among patients taking semaglutide. When considering whether Wegovy is cheaper than Mounjaro, these robust clinical outcomes support the medication's value proposition beyond simple cost comparison. Both medications may help with weight management, but patients should discuss their individual circumstances with a qualified prescriber.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. This prescription-only medicine works by activating GLP-1 receptors in the brain's appetite centres, potentially reducing hunger signals and promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, helping patients feel satisfied for longer periods. Unlike some weight management approaches, Wegovy's mechanism addresses the biological drivers of appetite rather than relying solely on willpower. Clinical studies suggest the medication can support reduced food cravings, making it easier for patients to maintain the reduced-calorie diet essential for successful weight management.
Streamlined Ordering Process for Private Prescription
Our private prescription service eliminates the complexities of NHS referral pathways when comparing Wegovy vs Mounjaro costs. Patients complete a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. A qualified prescriber reviews each application within 3 working days (or 24 hours with express service) to ensure clinical appropriateness. Once approved, medications are dispatched via next-day delivery using cold-chain temperature-controlled packaging. The entire process from assessment to delivery typically takes 4-5 days, compared to months through traditional NHS channels. Our GPhC-registered pharmacy (#9012878) ensures all medications meet the same quality standards as hospital-dispensed prescriptions.
Storage and Practical Considerations
When evaluating whether Wegovy is cheaper than Mounjaro, storage requirements affect practical usage costs. Wegovy offers superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature tolerance provides greater convenience for travel or daily use. The FlexTouch pen delivery system requires no mixing or preparation — patients simply attach a new needle for each weekly injection. Dose escalation follows a specific schedule starting at 0.25mg and increasing every 4 weeks until reaching the 2.4mg maintenance dose, with each strength requiring a separate prescription.
Private vs NHS Access for Weight Management Medications
The question "is Wegovy cheaper than Mounjaro" becomes more complex when considering NHS vs private costs. While NHS prescriptions cost £9.90 per item in England (free in Scotland, Wales, and Northern Ireland), accessing these medications through NHS routes requires meeting strict criteria and enduring significant delays. NICE guidance TA875 recommends Wegovy only within specialist weight management services, creating bottlenecks that can delay treatment by 6-18 months. Private prescription removes these barriers, allowing clinically appropriate patients immediate access regardless of postcode lottery variations in NHS service provision.
Many patients find that private prescription costs become comparable to NHS treatment when factoring in time off work for multiple appointments, travel expenses for specialist consultations, and the opportunity cost of delayed treatment. Private prescribing also allows for more flexible dosing adjustments and ongoing support without the rigid protocols that characterise NHS weight management programmes.
Making Your Treatment Decision
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option best suits your individual circumstances and budget. Our clinical team considers factors including medical history, previous treatment responses, lifestyle requirements, and cost considerations when making prescribing decisions. We provide ongoing support throughout your treatment journey, with regular check-ins to monitor progress and adjust dosing as needed. The convenience of private prescription, combined with our competitive pricing and professional clinical oversight, offers a compelling alternative to lengthy NHS waiting lists for suitable candidates seeking weight management support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
